Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Elastic urinal leg strap
22905309051
|
Elastic urinal leg strap | Urinal Systems | Incontinence Appliances | No data available |
|
Elastolabo gel
21011100300
|
Elastolabo gel | Other Appliances | Appliances | No data available |
|
Elave body oil
130201000BBLMA0
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Elave conditioner
190205500BCPUA0
|
Proprietary compound preparation BNF 1902055 | Other toiletry preparations | Other Drugs and Preparations | No data available |
|
Elave facial cleanser
190205500BCPSA0
|
Proprietary compound preparation BNF 1902055 | Other toiletry preparations | Other Drugs and Preparations | No data available |
|
Elave hand wash
190205500BCPTA0
|
Proprietary compound preparation BNF 1902055 | Other toiletry preparations | Other Drugs and Preparations | No data available |
|
Elave Intensive cream
21220000248
|
Elave Intensive cream | Emollients | Appliances | No data available |
|
Elave lotion
130201000BBLNA0
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Elave shower gel
190205500BCPVA0
|
Proprietary compound preparation BNF 1902055 | Other toiletry preparations | Other Drugs and Preparations | No data available |
|
Elbasvir 50mg / Grazoprevir 100mg tablets
0503032I0AAAAAA
|
Elbasvir/grazoprevir | Elbasvir/grazoprevir | Infections | No data available |
|
Eldepryl 10mg/5ml syrup
0409010T0BBACAL
|
Eldepryl | Selegiline hydrochloride | Central Nervous System | No data available |
|
Eldisine 5mg powder for solution for injection vials
0801040Q0BBAAAA
|
Eldisine | Vindesine sulfate | Malignant Disease and Immunosuppression | No data available |
|
Eldoquin 2% cream
1315000G0BEABAW
|
Eldoquin | Depigmenting agents | Skin | No data available |
|
Eldoquin 4% cream
1315000G0BEAAAL
|
Eldoquin | Depigmenting agents | Skin | No data available |
|
Elecampane root tincture
190606000BCUEA0
|
Proprietary compound preparation BNF 1906060 | Other tincture preparations | Other Drugs and Preparations | No data available |
|
ELECT Superabsorber dressing 10cm x 10cm square
20031700175
|
ELECT Superabsorber dressing 10cm x 10cm square | Wound Management & Other Dressings | Dressings | No data available |
|
ELECT Superabsorber dressing 10cm x 20cm rectangular
20031700177
|
ELECT Superabsorber dressing 10cm x 20cm rectangular | Wound Management & Other Dressings | Dressings | No data available |
|
ELECT Superabsorber dressing 20cm x 20cm square
20031700176
|
ELECT Superabsorber dressing 20cm x 20cm square | Wound Management & Other Dressings | Dressings | No data available |
|
ELECT Superabsorber dressing 20cm x 30cm rectangular
20031700178
|
ELECT Superabsorber dressing 20cm x 30cm rectangular | Wound Management & Other Dressings | Dressings | No data available |
|
Electrolade oral powder sachets banana
0902012H0BCAAAD
|
Electrolade | Oral rehydration salts | Nutrition and Blood | No data available |
|
Electrolade oral powder sachets blackcurrant
0902012H0BCADAD
|
Electrolade | Oral rehydration salts | Nutrition and Blood | No data available |
|
Electrolade oral powder sachets lemon and lime
0902012H0BCAGAD
|
Electrolade | Oral rehydration salts | Nutrition and Blood | No data available |
|
Electrolade oral powder sachets multiflavour
0902012H0BCAEAD
|
Electrolade | Oral rehydration salts | Nutrition and Blood | No data available |
|
Electrolade oral powder sachets orange
0902012H0BCACAD
|
Electrolade | Oral rehydration salts | Nutrition and Blood | No data available |
|
Electrorush ORS oral powder sachets orange
0902012H0BZADAQ
|
Electrorush | Oral rehydration salts | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.